Build a pancreatitis pathway: early fluids targets, nutrition rules, ERCP criteria, and…
- User
Build a pancreatitis pathway: early fluids targets, nutrition rules, ERCP criteria, and escalation/ICU triggers.
- Assistant
Acute Pancreatitis Management Pathway
Evidence Basis: Adapted from ACG 2013/2024 and AGA 2018 guidelines. Focus on mild-moderate cases initially; tailor to etiology (e.g., gallstone, alcohol, idiopathic).
1. Early Fluids Targets (First 24-48 Hours)
Goal: Optimize perfusion, prevent pancreatic necrosis. Use lactate-guided or dynamic targets to avoid fluid overload.
Phase Fluid Type & Rate Targets Monitoring Hour 0-6 (Aggressive) Lactated Ringer's (LR) preferred over NS5-10 mL/kg IBW/hr bolus (e.g., 350-700 mL/hr for 70kg) ↓ Lactate <2 mmol/LUrine output 0.5-1 mL/kg/hrSBP >90 mmHg (no vasoactives) q2-4h: Lactate, UOP, Cr, BUNAvoid HCT <35-40% Hour 6-24 (Titrate) ↓ to 3-5 mL/kg/hr if targets metTotal 250-500 mL/hr MAP ≥65 mmHgScvO2 ≥70% if CVP↓ BUN by 10-25% q4-6h vitals/labsStop bolus if edema/CVP >12 >24h (Maintenance) 1.5-2x maintenance (e.g., 2-3 L/day)↓ if AKI/CVP rise Persistent targets above Daily weights, I/O strict Pearls:
- Switch to albumin if massive resuscitation (>4L in 24h).
- Hold if shock → ICU/vasopressors.
2. Nutrition Rules
Goal: Minimize gut barrier dysfunction. Enteral > Parenteral. No routine NPO.
Severity (Predict w/ SIRS/BISAP at 48h) Timing Route & Type Mild (No organ failure, BISAP ≤2) <24h: Trial clear liquids when pain ↓ & hunger returns.Advance to low-fat solids Day 1-2. Oral preferred.NPO only if ileus/nausea. Moderate/Severe (BISAP ≥3, OF) Within 48h (ideally <24h): Start trophic EN (10-20 mL/hr).Ramp to 80% goal kcal by Day 3. Nasjejunal tube (preferred over NG if necrotizing).Polymeric formula (e.g., Peptamen).TPN only if EN contraindicated >7 days. All Prophylactic PPI if high risk.No routine probiotics. Goal: 25-30 kcal/kg/day, 1.5g prot/kg. Pearls:
- Failure to tolerate EN → post-pyloric tube.
- Reassess q24h; oral if improving.
3. ERCP Criteria
Indications: Biliary etiology only (↑ LFTs, stones on US/MRCP). Urgent = <24h; Early = 24-72h.
Timing Criteria Urgent (<24h) Cholangitis (fever + jaundice + abd pain; Tokyo criteria).OR Persistent bili obstruction (TBili >3 mg/dL + duct dilation). Early (24-72h) Gallstone pancreatitis w/ choledocholithiasis confirmed (MRCP/EUS/LAPC).High-risk labs: TBili >4, ALT >3x ULN, CBD >6mm. Delayed (>72h) Routine MRCP/LAPC → interval cholecystectomy.No ERCP if necrotizing w/o obstruction. Pearls:
- Pre-ERCP abx if cholangitis.
- MRCP/EUS > US for dx (sens 95%).
4. Escalation/ICU Triggers
Risk Stratify: At presentation & 48h (BISAP ≥3, APACHE II ≥8, SIRS ≥2 → high risk).
Trigger Action Single Organ Failure (Marshall ≥2) HOB >30°, q4h vitals, telemetry. Consult GI/Surg. Persistent Shock Fluids fail (lactate >4 despite 4L) → ICU, norepi, CVL/ScvO2. Respiratory RR >30, PaO2/FiO2 <300, new infiltrates → ICU, NIPPV → intubate if pH <7.3. Renal Cr ↑1.5x baseline or UOP <0.5 mL/kg/hr x6h → ICU, RRT eval. Other Necrosis >30% (CT Day 7 if persistent OF), hemorrhage, abd compartment (>20 mmHg) → ICU/SICU. Escalation Pathway:
- Ward: q4h vitals/labs, early fluids/EN.
- Step-down/IMC: BISAP 3-4, early OF.
- ICU: Any persistent OF >48h, necrotizing dz.
Imaging: CT only if dx unclear or complications (Day 7 earliest for necrosis). Pain: IV multimodal (acetaminophen + opioids); avoid NSAIDs.
Audit Metrics: Fluids in 1h, EN by 48h, mortality <1% mild / <20% severe. Consult local protocols.
Other models, same or similar prompt
Responses were produced in different, uncontrolled contexts (system prompts, settings, prior turns). This is not a benchmark.